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Abstract. 
 
The participation of nonmuscle myosins in 
the transport of organelles and vesicular carriers along 
actin filaments has been documented. In contrast, there 
is no evidence for the involvement of myosins in the 
production of vesicles involved in membrane traffic. 
Here we show that the putative TGN coat protein p200 
(Narula, N., I. McMorrow, G. Plopper, J. Doherty, K.S. 
Matlin, B. Burke, and J.L. Stow. 1992. 
 
J. Cell Biol.
 
 114:
1113–1124) is myosin II. The recruitment of myosin II 
to Golgi membranes is dependent on actin and is regu-
lated by G proteins. Using an assay that studies the re-
lease of transport vesicles from the TGN in vitro, we 
provide functional evidence that p200/myosin is in-
volved in the assembly of basolateral transport vesicles 
carrying vesicular stomatitis virus G protein (VSVG) 
from the TGN of polarized MDCK cells. The 50% re-
duced efficiency in VSVG vesicle release from the 
TGN in vitro after depletion of p200/myosin II could be 
reestablished to control levels by the addition of puri-
fied nonmuscle myosin II. Several inhibitors of the ac-
tin-stimulated ATPase activity of myosin specifically 
inhibited the release of VSVG-containing vesicles from 
the TGN.
 
T
 
ransport
 
 of proteins synthesized in the ER is me-
diated by vesicular carriers that shuttle membrane
components between successive stations along the
secretory pathway (Palade, 1975). Distinct sets of cytosolic
factors are involved in the release, transport, docking, and
fusion of these transport vesicles (Rothman, 1994). The
initial stage in transport, the release of nascent vesicles
from the donor compartment, is thought to occur in two
steps. The first step is the curvature of the donor mem-
brane into a bud, mediated by coat protein complexes re-
cruited by address-specific membrane receptors and, in
concentrative transport, by signals in the cytoplasmic do-
mains of cargo proteins (Müsch et al., 1996; Rothman and
Wieland, 1996; Schekman and Orci, 1996). The second
step is the fission of the nascent vesicle, an energy-requir-
ing membrane fusion event initiated from the luminal side
of the bud, which requires acetyl coenzyme A in the Golgi
complex (Glick and Rothman, 1987; Rothman and War-
ren, 1994), and the microtubule-associated GTP-depen-
dent motor protein dynamin in clathrin-coated vesicles
budding from the plasma membrane (Takel et al., 1995).
The number of cellular transport steps mediated by ves-
icles largely exceeds the number of known families of
coat–adaptor complexes. These are: (
 
a
 
) clathrin, with the
adaptor complexes AP1 at the TGN, AP2 at the plasma
membrane, and unknown adaptors at endosomes (Pearse
and Robinson, 1990; Stoorvogel et al., 1996); (
 
b
 
) COPI, at
the Golgi apparatus (Letourneur et al., 1994; Orci et al.,
1993
 
a
 
) and COPI-like molecules in endosomes (Whitney
et al., 1995); (
 
c
 
) COPII, involved in transport between ER
and Golgi (Aridor et al., 1995; Bednarek et al., 1995); and
(
 
d
 
) 
 
b
 
-NAP (Newman et al., 1995) and a novel adaptor
complex (Simpson et al., 1996), which were postulated to
mediate anterograde transport in neurons. From the TGN,
the major sorting compartment in the exocytic route,
newly synthesized proteins are sorted into vesicular path-
ways to lysosomes, regulated secretory granules, and the
plasma membrane. At least two biochemically and phar-
macologically distinct routes to the cell surface have been
recently identified in polarized and nonpolarized cells
(Ikonen et al., 1995; Müsch et al., 1996; Yoshimori et al.,
1996), as well as in yeast (Harsay and Bretscher, 1995). Of
all these post-TGN routes, only the clathrin/AP1 coat that
mediates the receptor-mediated packaging of lysosomal
hydrolases has been characterized; morphological evidence
exists for an additional, lace-like coat in the TGN (Ladin-
sky et al., 1994), but its composition and function are un-
known.
The recruitment of coat proteins from the cytosol into
budding vesicles is mediated by small monomeric GTP
binding proteins of the ADP ribosylation factor (ARF)
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1. 
 
Abbreviations used in this paper
 
: ARF, ADP ribosylation factor; BDM,
butanesdione monoxime; BFA, brefeldin A; HA, hemagglutinin; PFA,
paraformaldehyde; psi, pounds per square inch; VSVG, vesicular stomati-
tis virus G protein.
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Sar1 family (Rothman, 1994; Schekman and Orci, 1996)
and regulated by trimeric G proteins (Donaldson et al.,
1991; Robinson and Kreis, 1992). Consequently, coat pro-
tein assembly onto membranes is enhanced by GTP
 
g
 
S and
AlF
 
3
 
, and inhibited by the fungal metabolite brefeldin A
(BFA), which inhibits the GTP–GDP exchange in small
monomeric G proteins (Helms and Rothman, 1992). Pro-
teins that bind to isolated organellar membranes with sim-
ilarly regulated features are considered good candidates to
be components of novel coat complexes. One such protein
is p200, which binds to isolated Golgi membranes with
identical characteristics as COPI and was initially identi-
fied by an mAb (AD7) raised against peripheral Golgi
proteins (Narula et al., 1992). p200 has been detected on
TGN-associated nascent vesicles by immuno-EM (Narula
and Stow, 1995).
In this report we demonstrate that p200 is involved in
the release of vesicular stomatitis virus G protein (VSVG)
but not hemagglutinin (HA)–containing vesicles from the
TGN. To our surprise, sequence analysis of immunoiso-
lated p200 revealed a stretch of 19 amino acids with 100%
homology to human nonmuscle myosin II. In agreement
with this result, polyclonal antibodies against platelet myo-
sin II recognized in immunoblots p200 immunoprecipi-
tated from rat liver cytosol with the AD7 mAb. Previous
data had suggested roles for both myosin II (Mochida et
al., 1994) and unconventional myosins (Fath and Burgess,
1993; for review see Hasson and Mooseker, 1995) in a late,
postmicrotubular stage in the transport of apical or regu-
lated secretory vesicles across the cortical actin meshwork
(Bretscher, 1991; Muallem et al., 1995). However, to our
knowledge, there is no evidence for an early role of myo-
sin in the assembly of any kind of transport vesicles. The
data we present here demonstrate that myosin II is re-
cruited to isolated Golgi membranes with features charac-
teristic of coat proteins. Furthermore, a variety of myosin
functional tests shows conclusively that myosin mediates
the release of VSVG transport vesicles from the TGN of
semiintact MDCK cells and from a purified Golgi fraction.
Our data suggest that myosin II is part of the cytosolic ma-
chinery that regulates assembly or fission of a set of consti-
tutive transport vesicles from the TGN.
 
Materials and Methods
 
Cells, Viruses, and Antibodies
 
MDCK II cells, VSV (Indiana strain), and influenza virus A (WSN) were
grown as described (Rodriguez-Boulan and Sabatini, 1978). The protocols
for viral infection of MDCK cell monolayers, for pulse labeling, and for
TGN accumulation of the VSVG protein and the WSN HA, as well as the
antibodies against the viral markers, were described previously (Müsch et
al., 1996).
Other antibodies (sources) were as follows: polyclonal antibody against
human blood platelet myosin II (Biomedical Technologies, Inc., Stough-
ton, MA); polyclonal antibody against chicken brush border myosin II
(kindly provided by K. Fath and D. Burgess, University of Pittsburgh,
PA), affinity purified on myosin II from chicken brush border (kindly pro-
vided by K. Fath and D. Burgess); AD7 mAb against p200 (Narula et al.,
1992), prepared by a hybridoma kindly provided by K. Matlin (Harvard
University, Boston, MA); polyclonal antibody against human cathepsin D
(Biodesign Intl., Kennebunkport, ME); mAb against gp114 (hybridoma
Y-652 from K. Matlin, Harvard University); 
 
b
 
-COP mAb M3A4 (kindly
provided by T. Kreis, University of Geneva, Switzerland); affinity-purified
rab 8 polyclonal antibody, raised against a peptide corresponding to the
amino acids 182–197 of human rab 8 (Santa Cruz Biotechnology, Inc., Santa
Cruz, CA).
 
p200 and Actin/Myosin Depletion
 
100 
 
m
 
l rat liver cytosol (50 mg/ml) was incubated three times with 30 
 
m
 
g
immobilized antibodies against platelet myosin (300 
 
m
 
g IgG cross-linked
to 100 
 
m
 
l protein A–Sepharose; Pharmacia Fine Chemicals, Piscataway,
NJ), or p200 (300 
 
m
 
g IgG cross-linked to 50 
 
m
 
l protein G–agarose,
Gamma-Bind; Pharmacia Fine Chemicals). 3 mM Mg-ATP, pH 7.0, was
added during the last 10 min of each immunoisolation step to prevent
coisolation of actin. About 90% of cytosolic myosin or p200 was removed
with a loss of 15% of the total protein, as tested by Western blotting and a
Lowry assay, respectively. The amount of cytosol added in the recruit-
ment and vesicle release assays was corrected for the loss of total protein.
Mock-depleted cytosol was incubated under the same conditions with pro-
tein A–Sepharose or protein G–agarose alone.
 
Actin Depletion
 
Polymerization of actin in rat liver cytosol was stimulated with 50 
 
m
 
g/ml
phalloidin (Sigma Chemical Co., St. Louis, MO) and the actin filaments
were pelleted for 20 min at 27 pounds per square inch (psi) (150,000 
 
g
 
) in
an airfuge (A100/18
 
8
 
 rotor; Beckman Instruments Inc., Fullerton, CA). 5
mM Mg-ATP, pH 7.0, was added immediately before the spin when myo-
sin depletion was to be avoided. The actin or actin/myosin pellet was re-
suspended in the original volume of a buffer composed of 50 mM KCl, 5
mM MgCl
 
2
 
, 1 mM PMSF, 1 mM DTT, and 10 mM Tris/HCl, pH 7.0. To
elute myosin, the protein complex was incubated with 5 mM ATP, pH 7.0,
and actin fibers were repelleted for 20 min at 27 psi.
 
Vesicle Release in Semiintact Cells
 
The release of HA and VSVG transport vesicles from the TGN semiintact
cells was studied in the absence or presence of 2 mg/ml rat liver cytosol (1
and 2 mg/ml for the caldesmon experiments), as described (Müsch et al.,
1996). Before the assay, the semiintact cells were stripped off peripheral
membrane proteins with a high salt buffer (0.5 M KCl, 20 mM Hepes/
KOH, pH 7.4) as described (Müsch et al., 1996).
The S1 fragments prepared from chicken muscle myosin by either chy-
motryptic cleavage (Ch-S) or papain cleavage (Mg-S1) were kindly pro-
vided by Dr. S. Margossian (University of Albany, NY) and the 20-kD
COOH-terminal chymotryptic fragment of caldesmon was kindly pro-
vided by J. Chalovich (East Carolina University, Greenville, NC). Both
probes were directly incubated with the cytosol in the assay at the concen-
trations indicated in the text.
 
Vesicle Release from Purified Golgi Fractions
 
Golgi Membranes. 
 
Cells were homogenized with a Balch homogenizer
(Balch et al., 1984) after the accumulation of labeled VSVG in the TGN.
A fraction enriched in Golgi was isolated from a light mitochondrial frac-
tion by flotation on a Nycodenz step gradient (25, 17.5, and 10%), accord-
ing to the manufacturer’s protocol (Centrifugation Techniques VI; Ny-
comed, Oslo, Norway). Organelle markers (see Results; Table I) were
chosen as follows: for mitochondria, succinate dehydrogenase (Centrifu-
gation Techniques IV; Nycomed); for ER, 
 
a
 
-glucosidase II fluorescence as-
say, using 4-methyl umbelliferone (4MU)–
 
a
 
-
 
d
 
-glucoside (Sigma Chemical
Co.) as substrate; for Golgi, 
 
a
 
-mannosidase II fluorescence assay using
4MU-
 
a
 
-
 
d
 
-mannopyranoside (Sigma Chemical Co.) as substrate (Storrie
and Madden, 1990); for TGN, sialyltransferase (Brandli et al., 1988; Simon
et al., 1996); for lysosomes, immunoblot analysis of mature form of cathep-
sin D; for plasma membrane, immunoblot analysis of gp114 or dot blot
analysis of biotinylated membranes with 
 
125
 
I-streptavidin.
 
VSVG Vesicle Release from Purified Golgi Membranes. 
 
Aliquots of the
Golgi fraction (protein concentration 0.5 mg/ml) that were stored at
 
2
 
80
 
8
 
C for up to 2 mo were thawed rapidly, pelleted at 10,000 
 
g 
 
for 10 min,
incubated for 20 min in a high salt buffer (0.5 M KCl, 20 mM Hepes/KOH,
pH 7.4), repelleted, and resuspended in transport buffer (Müsch et al.,
1996) with 0.2 M sucrose. 2.5 
 
m
 
g Golgi and 20 
 
m
 
g rat liver cytosol were in-
cubated in 20 
 
m
 
l 1
 
3
 
 transport buffer and supplemented with 1 mM ATP,
pH 7.0, 1 mM GTP (or GTP
 
g
 
S in Fig. 2), 75 
 
m
 
M creatine phosphate, 0.5
mg/ml creatine kinase. Where indicated, 1 
 
m
 
l VSVG peptide (0.5 mM in
transport buffer; Müsch et al., 1996) or 1 
 
m
 
l platelet myosin II (2 mg/ml in
0.6 M KCl, 10 mM imidazole, pH 7.0), or 2.5 
 
m
 
l chicken brush border my-
osin (70 
 
m
 
g/ml in 7 mM imidazole, 2.8 mM EDTA, 0.7 mM EGTA, 
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0.014% NaN
 
3
 
, 0.7 mM DTT, 30% glycerol, pH 7.3) was added to the assay
mix. Control samples received 1 or 2.5 
 
m
 
l of the respective myosin buffers.
The samples were incubated for 60 min at 37
 
8
 
C and the Golgi membranes
were subsequently pelleted for 10 min at 10,000 
 
g
 
; both the supernatant
and pellet fractions were analyzed by SDS-PAGE.
Controls (not shown) performed to validate Golgi vesicle release assay
were as described in Müsch et al. (1996) and demonstrated: (
 
a
 
) protease
protection of VSVG in the vesicle fraction, and (
 
b
 
) endoglycosidase H re-
sistance and neuraminidase sensitivity of VSVG in the vesicle fraction.
 
Controls for TGN Fragmentation. 
 
The levels of nonspecific TGN frag-
mentation were determined by measuring the release of sialyltransferase
into the vesicle fraction. Assays studying vesicle release (1 ml reaction
mixture) from 125 
 
m
 
g cold Golgi fractions (nonradiolabeled membranes
containing VSVG, prepared in parallel with the radiolabeled membranes
used in the standard assay) were carried out in parallel with the standard
assays with 
 
35
 
S-radiolabeled Golgi membranes. The supernatant fractions
of the radioactive assay were adjusted to 1 ml with transport buffer, and
the supernatant fractions from both cold and hot assays were centrifuged
at 150,000 
 
g
 
 for 5 h in a Beckman TLA 100.3 rotor. One control was an
identically processed supernatant of a vesicle release assay lacking Golgi
membranes. One-fifth of each of the cold Golgi pellet fractions and the to-
tal cold vesicle pellets was resuspended in 200 
 
m
 
l of 10 mg/ml asialofetuin,
1% Triton X-100, 0.1 M cacodylate/NaOH, pH 6.6, and incubated with 0.1
 
m
 
Ci cytidine 5
 
9
 
-monophosphate–sialic acid (9 
 
3
 
H-sialic acid) for 2 h at
37
 
8
 
C. Subsequently, protein was TCA precipitated as described (Brandli
et al., 1988; Simon et al., 1996) and the incorporation of 
 
3
 
H-sialic acid into
asialofetuin was measured in a liquid scintillation counter. Previous exper-
iments had established that the enzymatic reaction was in the linear range
with the amount of Golgi and substrate used. The amount of VSVG in the
radioactive Golgi and vesicle pellets was quantified as described before
(Müsch et al., 1996).
 
Immunoisolation of Vesicles. 
 
After release from semiintact cells, the
vesicles were sedimented in an airfuge for 20 min at 27 psi; vesicles re-
leased from isolated Golgi membranes were isolated directly from the su-
pernatant fraction of a vesicle release assay. When a high salt wash pre-
ceded the isolation, samples were incubated in 500 mM KCl, 20 mM Tris/
HCl, pH 7.4, for 30 min, and the KCl concentration was adjusted to 150
mM before the antibodies were added. For analysis of rab 8 and 
 
b
 
-COP in
nonradiolabeled vesicles isolated with p200 antibodies, assays (1 ml) were
performed in the presence of GTP
 
g
 
S; the vesicles were pelleted for 5 h at
150,000 
 
g
 
 in a TLA 100.3 rotor; the pellet was resuspended in 500 
 
m
 
l of 1.5 M
sucrose, 1 mM DTT, 2 mM EDTA, 20 mM Hepes/KOH, pH 7.4; and the
vesicles floated in a step gradient of 1.45 ml 1.2 M sucrose and 250 
 
m
 
l of
0.6 M sucrose in the same buffer for 16 h at 45,000 rpm in a TLS-55 rotor.
The 0.6 M sucrose fraction, including the interphase with the 1.2 M frac-
tion, was harvested, and the vesicles were immunoisolated (see Fig. 2, 
 
B
 
and 
 
C
 
) using VSVG or p200 antibodies bound to secondary antibodies
that were covalently immobilized on magnetic Dynabeads Subcellular
M-500 (Dynal Inc., Great Neck, NY), according to the manufacturer’s in-
structions. The vesicle isolations described in Fig. 2 
 
A
 
 were carried out us-
ing immobilized protein G–agarose (Pharmacia Fine Chemicals).
 
Recruitment Assays
 
Recruitment of Cytosolic Proteins to Semiintact Cell Membranes. 
 
50 
 
m
 
g of high
salt washed semiintact cells (Müsch et al., 1996) was incubated with 1, 10,
or 100 
 
m
 
g of rat liver cytosol and 1 mM GTP
 
g
 
S in the absence or presence
of chicken Mg-S1 myosin at the indicated concentrations for 30 min at
37
 
8
 
C in 100 mM KCl, 2 mM MgCl
 
2
 
, 1 mM DTT, 1 mM PMSF, 20 mM
Hepes/KOH, pH 7.2. After two washes, the samples were analyzed by
Western blotting according to standard techniques.
 
Recruitment of Cytosolic Proteins to Golgi Membranes. 
 
Golgi membranes
were prepared as described above, except that the cell surface was bioti-
nylated with NHS-LC-biotin (Lisanti et al., 1989) before homogenization,
and plasma membrane contaminations of the Golgi fractions (400 
 
m
 
g
Golgi) were adsorbed with 50 
 
m
 
l neutravidin–agarose (Pierce Chemical
Co., Rockford, IL) and 100 
 
m
 
l WGA–agarose (Sigma Chemical Co.). 20
 
m
 
g of membrane protein was incubated in a 60-
 
m
 
l assay with 30 
 
m
 
g of rat
liver cytosol. The Golgi membranes were washed for 20 min on ice with
0.6 M KI in 20 mM Hepes/KOH, pH 7.2, before resuspension in assay
buffer, and incubation and processing were as described in the figure legends.
 
In Vivo Transport Assays
 
Pulse-labeled VSVG was accumulated in the TGN of VSV-infected
MDCK cells as described above, except that the cells were grown on poly-
carbonate filters. Alternatively, filter-grown monolayers were labeled for
10 min at 37
 
8
 
C with 0.5 mCi/ml [
 
35
 
S]methionine/cysteine and subsequently
chased for 2 h at 20
 
8
 
C. After the 20
 
8
 
C block, cells were washed with ice-
cold Hank’s solution (GIBCO BRL, Gaithersburg, MD), and either kept
on ice or subsequently incubated at 37
 
8
 
C with prewarmed Hank’s solution
in the presence or absence of 20 mM butanedione monoxime (BDM)
(Sigma Chemical Co.) added to both apical and basolateral chambers for
the time periods indicated in the text. Apical and basolateral media were
collected separately. In uninfected cells, total radioactivity was counted
directly in EcoLume (ICN Biomedicals Inc., Irvine, CA), in a liquid scin-
tillation counter, and the radioactivity was expressed as percentage of to-
tal (intracellular plus secreted) protein. Total cellular protein was ex-
tracted in 1% Triton X-100 for 30 min, TCA precipitated, and solubilized
in Solvable (Packard Instrument Co., Meriden, CT). VSVG-infected cells
were biotinylated at the basolateral surface before the Triton extraction,
and VSVG was immunoprecipitated from the cellular protein as well as
from the basolateral medium. The radioactivity in the VSVG immunopre-
cipitates from the medium as well as from one-tenth of the cellular VSVG
was counted directly, whereas the biotinylated fraction from nine-tenths
of the cell-associated VSVG was isolated on streptavidin–Sepharose
(Lisanti et al., 1989) and counted. Secreted and surface-associated VSVG
were expressed as percentages of the total cellular and secreted VSVG.
Previous control experiments had established that the VSVG antibody
does not precipitate radioactivity from uninfected cells.
 
Preparation of Rat Liver Cytosol
 
Rat livers were perfused with homogenization buffer (0.25 M sucrose, 20
mM Tris/HCl, pH 7.4, 1 mM EDTA, 1 mM DTT, 1 mM PMSF, 10 mg/ml
leupeptin, 10 mg/ml pepstatin, 10 mg/ml antipain) and homogenized in a
motor-driven potter homogenizer with 4 ml/g homogenization buffer, and
the postnuclear supernatant was pelleted for 2 h at 150,000 
 
g.
 
 The result-
ant supernatant was precipitated with saturated ammonium sulfate, resus-
pended in one-fifth of the original volume in 20 mM Tris/HCL, pH 7.4, 50
mM KCl, and dialyzed for 12 h with three changes against the same buffer
(100
 
3
 
 the volume). Aliquots were snap frozen and stored at 
 
2
 
80
 
8
 
C.
 
Preparation of Human Platelet Myosin II
 
Platelets from 700 ml of human blood were isolated as described in Wil-
liams et al. (1993). Nonmuscle myosin II from 0.5-g platelets was prepared
as described (Isenberg, 1995) according to Pollard (1982), and the protein
was stored at a concentration of 2 mg/ml in 0.6 M KCl, 10 mM imidazole,
pH 7.0, for 5 d on ice. Aliquots were stored at 
 
2
 
20
 
8
 
C in 50% glycerol for
up to 1 mo.
 
Immunofluorescence
 
For these experiments, confluent monolayers of MDCK cells were grown
on coverslips. Where indicated, the cells were incubated with 30 mM NaF/
30 
 
m
 
M AlCl
 
3
 
 for 30 min at 37
 
8
 
C before fixation/extraction. In some exper-
iments, to stimulate the release of cytosolic proteins and simultaneously to
allow the GTP
 
g
 
S-induced membrane recruitment of cytosolic coat pro-
teins, cells were incubated in 5 
 
m
 
g/ml digitonin for 10 min at 20
 
8
 
C (condi-
tions that permeabilize the plasma membrane, but not the Golgi; Esparis-
Ogando et al., 1994), and further incubated on ice for 20 min in the ab-
sence or presence of 1 mM GTP
 
g
 
S in PBS. Cells were fixed and extracted
in three different ways: (
 
a
 
) 2% paraformaldehyde (PFA)/PBS, with subse-
quent dehydration in ice-cold acetone for 1–3 min; (
 
b
 
) extraction in cy-
toskeletal buffer (Cramer and Mitchison, 1996) (138 mM KCl, 3 mM
MgCl
 
2
 
, 2 mM EGTA, 0.32 M sucrose, 0.1% Triton X-100, 10 mM MES,
pH 6.1) for 45 s, and subsequent fixation in 4% PFA in cytoskeletal buffer
without Triton X-100; and (
 
c
 
) fixation in 2% PFA/PBS, followed by per-
meabilization with 0.1% Triton X-100. Indirect immunolabeling was car-
ried out in 0.1% Triton in PBS, using Texas red–coupled anti–rabbit sec-
ondary antibodies and FITC-coupled anti–mouse secondary antibodies
for double immunofluorescence and FITC-phalloidin when indicated. The
samples were analyzed by laser scanning confocal microscopy.
 
Immuno-EM. 
 
Membrane recruitment assays with 15 
 
m
 
g Golgi mem-
branes were performed in the presence of cytosol and GTP
 
g
 
S as described
above. The membranes were spread on nickel grids that had been previ-
ously coated with Formvar and subsequently with poly-lysine. Membranes
were fixed with PLP (0.01 M periodate, 0.075 M lysine, 0.037 M sodium-
phosphate buffer, 2% PFA), quenched, and permeabilized with 10 
 
m
 
M 
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digitonin for 5 min at room temperature. The detergent was washed out
and the grids were blocked with 2% BSA/5% goat serum in PBS. Immu-
nogold labeling was performed in the same buffer with antibodies to p200
and to the ectodomain of VSVG. Negative staining was with 2% ammo-
nium molybdate for 1 min. Grids were observed in a JEOL-100 EX II
electron microscope (JEOL USA Inc., Peabody, MA) at 80 mV. The spec-
ificity of the labeling was confirmed by the omission of the first antibodies,
or of the detergent extraction (when antibodies against luminal epitopes
of VSVG were used).
 
Miscellaneous Techniques
 
Quantification of bands in fluorograms or autoradiograms was carried out
as described in Müsch et al. (1996). The percentage of VSVG vesicle re-
lease refers to the amount of VSVG in the supernatant fraction divided by
the sum of VSVG in the pellet and supernatant fractions. Protein concen-
trations were determined with the bicinchoninic acid assay kit from Pierce
Chemical Co.
 
Results
 
p200 Participates in the Release of VSVG Transport 
Vesicles from the TGN
 
The regulated association of p200 with the TGN of MDCK
cells (de Almeida et al., 1993) and its presence on nascent
vesicles (Narula and Stow, 1995) suggest a role in vesicle
production. To study whether p200 is functionally in-
volved in the formation of secretory vesicles, we used a
novel in vitro assay that measures the cytosol-dependent
vesicular release of the apical marker influenza HA or the
basolateral marker VSVG from the TGN of semiintact
MDCK cells (Müsch et al., 1996). After infection with ei-
ther VSV or influenza, the viral glycoproteins were pulse
labeled (15 min) with [
 
35
 
S]methionine/cysteine and subse-
quently accumulated in the TGN of MDCK cells using a
20
 
8
 
C temperature block (Matlin and Simons, 1983). MDCK
cells were then mechanically perforated, depleted of their
cytosolic and peripheral membrane proteins by a high salt
wash, and stimulated for vesicle release by incubation at
37
 
8
 
C, in the presence of rat liver cytosol and an energy re-
generating system. Typically, cytosol induces a three- to
fivefold increase in marker release into the supernatant.
Vesicles released from the TGN were separated from the
semiintact cells by a brief spin, and the amount of marker
protein in pellet and supernatant fractions was analyzed.
mAb AD7 depleted 
 
.
 
90% of p200 from cytosol, as
judged by immunoblots (Fig. 1 
 
A
 
). We confirmed previous
findings (de Almeida et al., 1993) that GTP
 
g
 
S stimulates
the recruitment of p200 from rat liver cytosol onto MDCK
membranes. High salt–washed membranes displayed no
p200 (Fig. 1 
 
B
 
, lane 
 
2
 
), but addition of control (lane 
 
3) or
mock-depleted (lane 4) cytosol resulted in efficient re-
cruitment of this protein. No p200 recruitment was ob-
served upon addition of p200 immunodepleted cytosol
(Fig. 1 B, lane 5). Immunodepletion of p200 from cytosol
had specific effects on the production of post-TGN trans-
port vesicles (Fig. 1 C). Cytosol immunodepleted of p200
had a 50% reduced ability to stimulate the release of
VSVG containing vesicles, as compared with control and
mock-depleted cytosol, but it was as effective as mock-
Figure 1. Reduced ability of
p200-depleted cytosol to
stimulate the release of
VSVG transport vesicles
from the TGN in semiintact
cells. (A) Immunodepletion
of p200. Equivalent aliquots
of control rat liver cytosol or
p200-immunodepleted cyto-
sol (as described in Ma-
terials and Methods) were
analyzed by SDS-PAGE,
transferred to polyvinylidene
difluoride membranes, and
probed with p200 antibodies.
(Lanes Coomassie) Eluant
from immunobeads, control
cytosol, and p200-immuno-
depleted cytosol samples, an-
alyzed by SDS-PAGE and
stained with Coomassie blue.
(B) Western blot of mem-
brane-bound p200 recruited
from rat liver cytosol. (Lane
1) cytosol; (lane 6) p200 elu-
ant from immunobeads;
(lanes  2–5) high salt–washed
semiintact cells were incu-
bated in the presence of 1
mM GTPgS with no cytosol
(lane 2), control cytosol (lane 3), mock-depleted cytosol (lane 4), or p200-depleted cytosol (lane 5). (C) Supernatant fractions of a
VSVG (left) or HA (right) vesicle release assay in the presence of no cytosol (lane 1) or control cytosol (lane 2), p200-depleted cytosol
(lane 3), or mock-depleted cytosol (lane 4). (D) VSVG and HA released from semiintact cells in an in vitro vesicle release assay, ex-
pressed as a percentage of the total marker in supernatant and pellet fractions. Mean and standard errors from five experiments.Müsch et al. Myosin in Vesicle Budding from the TGN 295
depleted cytosol in stimulating the release of HA-contain-
ing vesicles (Fig. 1 C, compare lane 3 with lanes 2 and 4,
for both VSVG and HA). The results of the vesicle release
experiments, represented graphically in Fig. 1 D, suggest a
functional role of p200 in the production of VSVG trans-
port vesicles.
p200 Is Present in VSVG Transport Vesicles Released 
from Semiintact Cells
If p200 is involved in the formation of VSVG transport
vesicles, it should be detected at the vesicle surface imme-
diately after release. Indeed, immunoprecipitation experi-
ments initially carried out with vesicles released from
semiintact MDCK cells (Fig. 2 A) showed that p200 anti-
bodies immunoisolated intact VSVG transport vesicles,
but not HA transport vesicles (Fig. 2 A, VSVG and HA
panels, lanes 4 and 5). Control experiments confirmed our
previous observations (Müsch et al., 1996) that luminal
epitopes of VSVG and HA were accessible to specific an-
tibodies only after solubilization of the vesicular mem-
brane with Triton X-100 (Fig. 2 A, compare lane 1 with
lane 3 in both VSVG and HA panels). In contrast, anti-
bodies against cytoplasmic epitopes of these proteins were
effective in immunoisolating VSVG and HA intact vesicle
populations in the absence of detergent; however, a high
salt wash was required for efficient precipitation, presum-
ably to remove proteins that masked these cytoplasmic
epitopes (Fig. 2 A, lane 2).
VSVG Transport Vesicles Released from Purified Golgi 
Fractions Contain p200
To facilitate the manipulation of Golgi membranes before
or during the in vitro vesicle release assay, we carried out
experiments using a purified Golgi fraction, obtained from
cells that had accumulated viral glycoprotein in the TGN
during an incubation at 208C (see Materials and Methods).
When used for the in vitro assay, the high salt–washed
Golgi fraction supported cytosol-induced release of vesi-
cles carrying VSVG (Fig. 2 B, compare lanes 2 and 3). To
study the presence of p200 in the coat of VSVG transport
vesicles, all experiments shown in Fig. 2 B were carried out
in the presence of the nonhydrolyzable GTP analogue
GTPgS, which promotes coat retention without affecting
vesicular release from Golgi complex (Orci et al., 1993b)
Figure 2. Antibodies against
p200 and myosin immunoiso-
late VSVG- but not HA-con-
taining post-TGN vesicles.
(A) The supernatant frac-
tion of a VSVG (left) or HA
(right) vesicle release assay,
carried out in semiintact cells
in the presence of cytosol,
was precipitated in an airfuge
at 150,000 g and the vesicles
were immunoprecipitated
with antibodies against the
ectodomain of VSVG or HA
in the absence (lane 1) or
presence (lane 3) of Triton
X-100. HA and VSVG trans-
port vesicles, stripped of coat
proteins with a high salt
buffer, were immunoprecipi-
tated in the absence of Triton
with an anti-tail antibody
(lane  2), p200 antibody fol-
lowed by VSVG/HA ecto-
domain antibody (lane 4),
p200 antibody alone (lane 5),
and myosin antibody, fol-
lowed by VSVG or HA ectodomain antibody (lane 6). Immunoprecipitation of VSVG and HA from the Triton-solubilized vesicle frac-
tions was quantitative with antibodies against the ectodomain (lane 3 in both panels); immunoisolation of VSVG with the p200 antibody
was 30% (lane 5). (B) The pellet (G) or supernatant fractions (V) of a VSVG vesicle release assay, performed with a Golgi-enriched
membrane fraction (see Materials and Methods) in the absence (lane 2) or presence (lanes 3–9) of cytosol and 1 mM GTPgS, were sub-
jected to immunoprecipitation with an antibody against the ectodomain of VSVG (lanes 1–6) or the p200 antibody (lanes 7–9). The
samples in lanes 5, 6, and 9 were incubated for 30 min on ice in the presence of 500 mM KCl before the salt concentration was adjusted
to 150 mM and the antibodies were added. The samples were immunoprecipitated in the absence of detergent (lanes 4, 6, 7, and 9) or in
the presence of 1% Triton X-100 (lanes 1, 2, 3, 5, and 8). 80% of the total VSVG in the vesicle fraction was immunoisolated with the
p200 antibody (compare lanes 3 and 7). (C) Pellet (P) and supernatant fractions (S) of a VSVG vesicle release assay, performed with a
Golgi-enriched fraction in the presence of cytosol and GTPgS. The vesicle fraction was purified from the supernatant by a flotation gra-
dient (see Materials and Methods) and immunoisolated with antibodies to p200 (lane 3) or mock immunoisolated (lane 2). Pellet and
immunoisolated vesicle fractions were probed in Western blot analysis using 125I–protein A for the presence of VSVG, rab 8, and
b-COP. The rab 8 blot was exposed 10 times as long as the VSVG and b-COP blots. One-fifth of the pellet fraction and the total of the
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or TGN (Simon et al., 1996; see Fig. 4). GTPgS prevents
coat release by locking the small GTP binding proteins
Sar1/Arf1 in the GTP state (Rothman, 1994). VSVG in
vesicles released under these conditions was latent; i.e., it
was immunoprecipitated by ectodomain antibodies only
after addition of detergent (Fig. 2 B, compare lanes 3 and
4). Strikingly, VSVG transport vesicles released in the
presence of GTPgS were more efficiently immunoprecipi-
tated by p200 antibodies than vesicles released in the pres-
ence of GTP (compare Fig. 2 B, lanes 3 and 7, with Fig. 2
A, lanes 3 and 5). Precipitation with p200 antibodies was
reduced by prior treatment of the vesicles with 500 mM
KCl or 1% Triton X-100 (Fig. 2 B, compare lane 7 with
lanes 8 and 9). These experiments demonstrated that p200
behaves like a peripheral vesicular coat protein, and that
VSVG and p200 do not interact directly but likely through
the membrane of a common transport vesicle. Additional
experiments provided support to the hypothesis that
VSVG transport vesicles purified by p200 antibody precip-
itation are involved in anterograde transport (Fig. 2 C).
Rab 8, a component of basolateral transport vesicles that
carry VSVG protein (Huber et al., 1993), was detected by
immunoblot in the isolated vesicle fraction. On the other
hand, b-COP, reportedly involved in anterograde and ret-
rograde transport between the ER and Golgi, was not de-
tected under the same conditions.
Electron microscopic examination of purified Golgi
fractions incubated with cytosol and GTPgS, in which
VSVG and p200 had been labeled with two different sizes
of colloidal gold particles, revealed the dual presence of
VSVG and p200 in vesicular structures of z80 nm (Fig. 3).
In these experiments, we labeled VSVG with ectodomain
(luminal) antibodies in the presence of a brief digitonin
treatment, since our vesicle precipitation experiments
(Fig. 2 A) predicted that epitopes in the cytoplasmic tail of
VSVG would not be readily accessible after GTPgS treat-
ment, presumably because of coat protein recruitment.
Specificity for VSVG and p200 labeling was supported by
various controls, including the absence of label with anti-
bodies against luminal epitopes when digitonin was not
present. Taken together, our data suggest that p200 partic-
ipates specifically in the release of basolateral vesicles
from the TGN.
VSVG Vesicle Release Is Not Caused by Fragmentation 
of the TGN
The biochemical and morphological data presented above
strongly support the presence of p200 in VSVG-containing
transport vesicles. However, to demonstrate conclusively
that the vesicle release observed in our in vitro assays is
the result of a specific vesicle assembly mechanism rather
than fragmentation of the Golgi membranes, we studied
the release of sialyltransferase, a TGN marker enzyme.
Fig. 4 shows that the percentage of sialyltransferse re-
leased from the Golgi in standard assays in the presence of
GTP or GTPgS was small compared to that of VSVG (3%
vs 22% in the presence of GTP; 1.7 vs 24% in the presence
of GTPgS). Furthermore, whereas depletion of p200 re-
duced the release of VSVG by .50% (to 10.3%), it did
not significantly change the release of sialyltransferase
(2.8%). These results indicate that our assay measures a
Figure 3. p200 colocalizes with VSVG on MDCK Golgi mem-
branes. Negative stain of MDCK Golgi membranes that were in-
cubated with GTPgS and cytosol before fixation and permeabili-
zation with digitonin. Immunogold labeling was carried out with
primary antibodies to p200 (10 nm gold) and antibodies to the
ectodomain of VSVG (5 nm gold). Bars, 100 nm.Müsch et al. Myosin in Vesicle Budding from the TGN 297
specific vesicle release mechanism, not Golgi fragmenta-
tion.
p200 Is Nonmuscle Myosin
To obtain sequence information on p200, we immobilized
the single 200-kD SDS-PAGE band obtained by immuno-
precipitation with AD7 from rat liver cytosol. A 19–amino
acid fragment produced by endoproteinase revealed, after
sequencing, 100% identity to nonmuscle myosin II, iso-
lated from human macrophages, and to rat neuronal myo-
sin II (Fig. 5 A). Fig. 5 B shows that a polyclonal antibody
against nonmuscle myosin recognized p200 immunopre-
cipitated from rat liver cytosol with the mAb AD7. Dou-
ble immunofluorescence labeling with a p200 mAb and an
affinity-purified polyclonal antibody against chicken brush
border myosin indicated that both proteins colocalized at
Golgi-like perinuclear structures (Fig. 6, A and B). The
Golgi staining with myosin II and p200 antibodies was
only observed when the cell membranes had been pre-
served by paraformaldehyde fixation (Fig. 6, A–F) and
was highly enhanced by pretreatment with AlFx (Fig. 6, A,
B, D, and F), consistent with the reported recruitment of
p200 to the Golgi complex in the presence of AlFx (de
Almeida et al., 1993). The effect of AlFx was maximal with
30 mM NaF/50 mM AlCl3 (as used by de Almeida et al.,
1993), but enhanced perinuclear staining could be ob-
served already with F2 concentrations as low as 10 mM
(data not shown), suggesting that the effect of AlFx was
due to an activation of trimeric G proteins rather than dis-
tinct effects of F2 on fluoride-sensitive enzymes (Brewer
and Roth, 1995; Mathews, 1970; Wiseman, 1970). On the
other hand, in cells extracted briefly in cytoskeleton-pre-
serving buffer and subsequently fixed in 4% paraformal-
dehyde (Cramer and Mitchison, 1996; Symons and Mitchi-
son, 1991), p200 and myosin colocalized with actin stress
fibers labeled with FITC-phalloidin, a staining pattern in
agreement with the reported distribution of cytoplasmic
myosin in cultured nonmuscle cells (Cramer and Mitchi-
son, 1996). Finally, in cells extracted and fixed with ace-
tone at 2208C, both antibodies revealed mainly diffuse cy-
toplasmic and plasma membrane staining (Fig. 6, K and L).
Two different scenarios may account for these findings:
(a) p200 is myosin II, can be recruited to the TGN in a
GTP-dependent manner, and is involved in the release of
VSVG-containing vesicles; and (b) the AD7 antibody
cross-reacts with myosin II, but the release of VSVG
transport vesicles is promoted by a different, less abun-
dant, 200-kD protein in the cytosol, which is not detected
by microsequencing. We carried out a series of experi-
ments designed to test whether myosin is involved in the
release of TGN transport vesicles and to discriminate be-
tween the two scenarios described above.
Myosin II from Three Different Sources Restores
the Activity of Rat Cytosol Depleted of p200 to Promote 
Vesicle Release
If p200 is myosin II, depletion of myosin II with specific
antibodies should result in specific inhibition of the pro-
duction of VSVG transport vesicles in the in vitro assay, as
shown for p200, and purified myosin II should restore the
activity of p200-depleted cytosol. Indeed, cytosol that was
immunodepleted of myosin II with polyclonal antibodies
against human platelet myosin II (Fig. 7 B, compare lanes
1 and 2) had a z50% reduced ability to stimulate the re-
lease of VSVG transport vesicles from semiintact cells, but
stimulated normally the release of HA transport vesicles
(Fig. 7, C and D). These results are identical to those de-
scribed before (Fig. 1) for the p200 antibody AD7. The full
activity of myosin-depleted cytosol in stimulating vesicle
release was recovered (Fig. 7 C, lane 4), or even increased
above control levels (Fig. 7 C, lane 6), by the addition of a
myosin II–enriched cytosol fraction, purified from rat liver
cytosol by binding to phalloidin-stabilized actin filaments
in the absence of ATP and released in the presence of
ATP (Fig. 7 A). These data strongly support a myosin role
in vesicle release from the TGN and provide additional ev-
idence that p200 is myosin II.
Because the myosin II used in the experiment just de-
scribed was purified from rat cytosol, the data above are
also consistent with a scenario in which p200 and myosin
are two different proteins that are independently involved
in vesicle release from the TGN. To critically test this pos-
sibility, we carried out complementation experiments with
muscle myosin II, isolated from human platelets by an in-
dependent chromatographic procedure (Fig. 8 A). Whereas
rat cytosol stimulates z2.5-fold the release of VSVG vesi-
Figure 4. Golgi fragmentation does not account for p200-depen-
dent release of VSVG-containing vesicles. Release of the TGN
resident enzyme sialyltransferase into the vesicle fraction of
VSVG vesicle release assays performed from nonradiolabeled
Golgi membranes in parallel with assays from Golgi membranes
with radiolabeled VSVG as described in Materials and Methods
in the absence of cytosol (A), the presence of control cytosol and
GTP (B), the presence of control cytosol and GTPgS (C), or the
presence of p200-depleted cytosol (D). Enzymatic activity of sial-
yltransferase (solid bars) and the amount of radiolabeled VSVG
(striped bars) were measured as described in Materials and Meth-
ods. The activities/amounts of both markers are expressed as per-
centages of the activity/amount in the Golgi and vesicle fractions
combined. Data are means from two experiments.The Journal of Cell Biology, Volume 138, 1997 298
Figure 5. The p200 antibody
AD7 recognizes a myosin II.
(A) p200, immunoprecipi-
tated from rat liver cytosol
with the AD7 antibody, was
transferred to polyvinyli-
dene difluoride membranes
and cleaved with endopro-
teinase Lys-C. A 19–amino
acid peptide was sequenced
and aligned with the se-
quences available from the
National Institutes of Health
gene bank and EST database
(Sequencing Facility, Rockefeller University, New York). Note sequence homology with three nonmuscle myosins II from three differ-
ent origins. (B) Total rat liver cytosol (lane cytosol) or the AD7 immunoprecipitate from rat liver cytosol (lane p200) was probed by im-
munoblot analysis with antibodies against human platelet myosin II.
Figure 6. Colocalization of myosin II and p200 in the Golgi of MDCK cells treated with AlFx. MDCK monolayers were incubated in the
presence (A, B, D, and F) or absence (C, E, and G–L) of AlFx (30 mM NaF/50 mM AlCl3) for 30 min before they were processed as fol-
lows: (A–F) fixation in 2% PFA in PBS, extracted in 0.1% Triton X-100; (G–J) extracted in cytoskeleton buffer, fixed in 4% PFA in cy-
toskeleton buffer (see Materials and Methods); (K and L) fixed in 2% PFA, acetone extracted. Indirect immunofluorescence was per-
formed with antibodies against either platelet myosin (pI) (E, F, J, and K), chicken brush border myosin II (bb) (C and D), or the p200
antibody AD7 (H and L). Double fluorescence of MDCK cells with FITC-phalloidin and platelet myosin (I and J), or p200 (G and H)
antibodies that were incubated with Texas red–conjugated secondary antibody. Double immunofluorescence with affinity-purified anti-
body to myosin II from chicken brush border and p200 was performed in A and B. The samples were analyzed by laser scanning confo-
cal microscopy.Müsch et al. Myosin in Vesicle Budding from the TGN 299
cles from an enriched Golgi fraction, immunodepletion of
p200 with mAb AD7 results in background levels of vesi-
cle release, equivalent to those observed in the absence of
any cytosol (Fig. 8 B). However, the addition of isolated
human platelet myosin II is sufficient to reconstitute the
vesicle release back to (and even slightly above) control
levels. Similar results were obtained with purified chicken
brush border myosin II (data not shown).
We and others (Müsch et al., 1996; Pimplikar et al.,
1994) have recently shown that a synthetic peptide identi-
cal to the cytoplasmic domain of VSVG inhibits the re-
lease of VSVG-containing vesicles from the TGN in vitro.
When incubated at the half-maximal inhibitory concentra-
tion with p200-depleted cytosol in the assay, the already
low efficiency of vesicle release is further decreased to
background levels (Fig. 8 B, lanes 9 and 10). The addition
of myosin II in the presence of the VSVG peptide results
in a stimulation of vesicle release, without, however,
reaching the levels observed with control cytosol in the ab-
sence of the peptide (Fig. 8 B, lanes 11 and 12). This result
indicates that depletion and readdition of myosin to the
system do not change the mechanism of VSVG vesicle re-
lease. Rather, the data support the hypothesis that myosin
and the VSVG peptide act on one and the same pathway
of vesicle formation and release.
Functional Evidence for the Involvement of Myosin in 
the Release of VSVG Transport Vesicles
To provide independent functional evidence for the in-
volvement of a myosin in the release of VSVG transport
vesicles from the TGN, we tested experimental conditions
that either inhibit the actin-dependent myosin ATPase ac-
tivity or uncouple energy hydrolysis from force generation
in the acto–myosin complex. The chymotryptic NH2-ter-
minal fragment of both muscle and nonmuscle myosin (S1
fragment) contains the myosin “heads” with both the actin
and the ATP binding site, and shows a similar actin-depen-
dent ATPase activity as the intact molecule (Hynes et al.,
1987; Kishino and Yanagida, 1988). S1 lacks the ability of
intact myosin to dimerize (controlled by the myosin tail),
and therefore cannot transduce nucleotide hydrolysis into
force generation, which is achieved by myosin dimers slid-
ing actin filaments against each other; however, since S1
competes with myosin for the binding of actin, it is there-
fore expected to inhibit any process that involves the
force-generating ATPase activity of myosin. Fig. 9 A
shows the effect of S1 prepared from muscle myosin on
the recruitment of myosin from rat liver cytosol to the
membrane fraction of semiintact MDCK cells. High salt–
washed, semiintact MDCK cells were incubated with two
Figure 7. Myosin II-depleted
cytosol has a reduced ability
to stimulate the release of
VSVG transport vesicles from
the TGN in semiintact MDCK
cells. (A, upper panel) Immu-
noblot of myosin-depleted
cytosol with myosin and actin
antibodies. Myosin was re-
moved from the cytosol by
sedimentation with phalloi-
din-polymerized actin fibers
in the absence of ATP (lane
2); depletion was prevented
by addition of 5 mM Mg-
ATP (lane 3); the resus-
pended actin–myosin pellet
obtained in the absence of
ATP (lane 5) was incubated
with 5 mM Mg-ATP to re-
lease myosin, and actin fila-
ments were removed by sedi-
mentation (lane 4). (Lower
panel) Coomassie-stained gel
showing control cytosol and
the myosin-enriched fraction
prepared from it (corre-
sponding to lanes 1 and 4 of
the upper panel, respec-
tively). (B) Immunoblot of
cytosol samples with myosin and actin antibodies. Cytosol depleted with polyclonal antibodies against nonmuscle myosin coupled to
protein A–Sepharose (lane 1); control cytosol (lane 2); cytosol mock-depleted with protein A–Sepharose alone (lane 3); and myosin,
eluted from the immunobeads. (C) Vesicle fractions of VSVG (upper panel) or HA (lower panel) vesicle release assays performed in
the absence of cytosol (lane 1), with control cytosol (lane 2), mock-depleted cytosol (lane 3), myosin-depleted cytosol (lane 5), myosin-
depleted cytosol supplemented with myosin eluted from the actin/myosin pellet in A (lane 4), or control cytosol supplemented with my-
osin released from the actin pellet (lane 6). (D) Data from four independent experiments similar to C. VSVG and HA released into the
supernatant fractions were expressed as a percentage of the total marker in supernatant plus pellet fractions. Results were expressed as
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Figure 8. Human platelet
myosin II can substitute for
p200 in the production of
VSVG transport vesicles. (A)
Coomassie stain (lane 1) of
myosin II isolated from hu-
man platelets. The 100-kD
band represents a degrada-
tion product as confirmed in
a myosin immunoblot (lane
2). (B) Supernatants of an as-
say studying the release of
VSVG-containing vesicles
from a Golgi-enriched mem-
brane fraction. Golgi mem-
branes were incubated with
an energy-regenerating mix
in the presence of: no cytosol
(lane  1), control cytosol
(lanes  2 and 3), p200-immuno-
depleted cytosol (lanes 4 and
5), p200-depleted cytosol and
myosin II (lanes 6 and 7),
p200-depleted cytosol and
25  mM VSVG peptide (lanes
8 and 9), or p200-depleted
cytosol, VSVG peptide, and
myosin II (lanes 10 and 11)
as described in Materials and
Methods. After the incuba-
tion, the Golgi membranes
were separated from the ves-
icle fraction and both frac-
tions were analyzed directly
by SDS-PAGE. (C) Quanti-
fication of the data from four
individual experiments simi-
lar to B.
different amounts of rat liver cytosol in the presence of
GTPgS, and the amount of myosin recruited to the mem-
brane fraction during 30 min at 378C was determined by
immunoblot, with the AD7 mAb against p200 (Fig. 9 A,
lanes 1–3). Addition of muscle S1 in z103 molar excess
over cytosolic myosin effectively competed with the re-
cruitment of this protein at both cytosol concentrations
(Fig. 9 A, lanes 4–6; note that AD7 cross-reacts with S1).
Furthermore, S1 fragments prepared by either papain
(Mg-S1) or chymotryptic (Ch-S1) cleavage from muscle
myosin II inhibited the release of VSVG transport vesicles
from the TGN in the in vitro assay (Fig. 9 B), suggesting
that the catalytic region of myosin is needed for this pro-
cess. VSVG release from the TGN was also inhibited by a
chymotryptic 20-kD COOH-terminal fragment of caldes-
mon, a protein that regulates actin–myosin binding in
smooth muscle and nonmuscle cells (Fig. 9 C) (Velaz et al.,
1993).
Additional functional evidence for a role of myosin in
vesicle release from the TGN was provided by experi-
ments with BDM, an effective and specific inhibitor of
nonmuscle myosin ATPase activity in vitro (Cramer and
Mitchison, 1996). Fig. 10 A shows that BDM strongly in-
hibits the release of VSVG transport vesicles in vitro but
did not affect the release of HA transport vesicles.
Data from cultured PtK2 cells suggest that BDM rapidly
enters into cells, when added to the culture medium, and
promotes redistribution of myosin away from stress fibers
(Cramer and Mitchison, 1996). These data led us to test
whether BDM affected the post-Golgi transport of VSVG
in vivo. Indeed, we observed (Fig. 10 B) that addition of
BDM immediately after the 208C block that accumulated
VSVG in the TGN resulted in a reproducible reduction of
37.5% (P , 0.05) of the delivery of VSVG to the basolat-
eral surface, or of 30.5% (P , 0.03) of the release of
VSVG in virions to the basolateral medium after 15 min of
incubation at transport-permissive temperature. In agree-
ment with this result, BDM affected total basolateral se-
cretion from uninfected MDCK cells differently from api-
cal secretion. Whereas total basolateral secretion was
significantly inhibited (by 17%, P , 0.05) after 30 min of
transport, total apical secretion was slightly stimulated
(15%,  P  , 0.02). The effect of BDM, however, was tran-
sient. When transport to the surface was followed over 1 h
in the presence of BDM, neither VSVG transport nor ba-
solateral secretion was consistently affected by the drug.
In fact, all reports of in vivo effects of the drug on myosin
are studies of short-term effects (in the range of minutes).
It is not clear whether the transient effect of BDM on ba-
solateral transport reflects inactivation of the drug overMüsch et al. Myosin in Vesicle Budding from the TGN 301
longer time courses or, alternatively, adaptation of the cell
through redundant mechanisms that compensate for the
inhibition of myosin function (see Discussion).
Binding of Myosin II to Golgi Membranes Involves 
Trimeric G Proteins and Actin
To characterize the role of myosin in vesicle formation, we
studied the conditions under which myosin binding to iso-
lated Golgi membranes could be observed. A Golgi-enriched
membrane fraction purified from MDCK cells, with low
contamination levels by ER, lysosomes, mitochondria, and
plasma membrane markers (Table I), was washed in 0.6 M
KI to remove associated actin and myosin. The recruit-
ment of myosin under various experimental conditions
was assessed by immunoblot. Recruitment requires GTP
or its nonhydolyzable homologue GTPgS and is stimu-
lated by AlFx (Fig. 11 A). BFA, which prevents the bind-
ing of the small GTP binding protein ARF to the Golgi,
inhibits myosin recruitment in the presence of GTP, but
the effect can be overcome by incubating the Golgi mem-
branes in the presence of both BFA and AlFx (Fig. 11 B).
Fig. 11 B further reveals that myosin binding to isolated
Golgi membranes is always accompanied by the recruit-
ment of actin. The association of actin with Golgi mem-
branes is also regulated by GTP binding proteins and is
sensitive to BFA. The fact that ATP prevented the Golgi
recruitment of myosin in the presence of GTPgS (Fig. 11
A, lane 5) is consistent with myosin binding to Golgi-asso-
ciated actin. To test whether myosin recruitment to the
Golgi requires actin, we reduced the actin concentration in
the cytosol by 80% by sedimentation of phalloidin-stabi-
lized actin filaments in the presence of ATP (to prevent
myosin binding) at 150,000 g (Fig. 11 C). Although the re-
sulting cytosol has normal myosin levels (Fig. 11 C, lane 7
vs lane 8), myosin recruitment to the Golgi is drastically
reduced (Fig. 11 C, compare lane 2 and 3). The addition of
a myosin fraction alone is not sufficient to increase the
amount of myosin at the membrane (Fig. 11 D, lane 4), but
the actin/myosin complex has to be incubated to reestab-
lish the GTPgS-dependent binding of myosin to the Golgi
(Fig. 11 D, lane 6). Additional cytosolic proteins seem to
be involved in the recruitment process since actin was not
able to recruit myosin to the Golgi in the absence of cyto-
Figure 9. Competitors of ac-
tin–myosin interactions in-
hibit the release of VSVG
containing vesicles. (A) Myo-
sin S1 fragment competes
with myosin recruitment to
semiintact cells. High salt–
washed semiintact cells were
incubated with 1 mg (lanes 1
and 4), 10 mg (lanes 2 and 5),
and 100 mg (lanes 3 and 6) of
rat liver cytosol and 1 mM
GTPgS at 378C in the ab-
sence (lanes 1–3) or presence
of 0.25 mg (lane 4), 2.5 mg
(lane  5), or 25 mg (lane 6) of
chicken muscle S1 fragment
(S1-Mg). After the incuba-
tion, the semiintact cells were
washed twice to remove un-
bound cytosolic factors and
analyzed by SDS-PAGE and
immunoblot analysis with
p200 antibody AD7. Note
that this antibody also reacts
with the S1 fragment. (B)
Myosin S1 fragment inhibits
the release of VSVG-con-
taining vesicles. Vesicle frac-
tions from VSVG vesicle re-
lease assay in the absence
(lanes 1 and 2) or presence
(lanes 3–8) of cytosol were
immunoprecipitated with antibodies against VSVG in the presence of Triton X-100 (lanes 2, 4, 6, and 8) or with antibodies against p200
(lanes 1, 3, 5, and 7) in the absence of Triton X-100. Samples from lanes 5 and 6 and 7 and 8 were incubated with an estimated 103 mo-
lar excess of S1-Mg (generated by papain cleavage) or Ch-S1 (generated by chymotryptic cleavage) over myosin in the cytosol during
the reaction (myosin was estimated to account for 5% of all cytosolic proteins). Data are from two independent experiments. (C) The
20-kD COOH-terminal fragment of caldesmon inhibits the release of VSVG-containing vesicles. (Upper panel) Supernatant fractions
of a VSVG vesicle release assay performed in the absence (lane 1) or presence of 1 mg/ml (10 mg) (lanes 2 and 4) or 2 mg/ml (20 mg)
(lanes 3 and 5) cytosol, and in the absence (lanes 1, 2, and 3) or presence of 0.5 mg (lane 4) and 1 mg (lane 5) caldesmon fragment.
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sol (Fig. 11 C, lane 5). These data, together with the obser-
vation that the actin binding fragment of myosin, S1, inhib-
its the recruitment of myosin to semiintact cell membranes
(Fig. 9 A), suggest that myosin binds to Golgi-associated
actin.
Discussion
p200 Is a Myosin II and Is Involved in the Release of 
VSVG Vesicles from the TGN
In this report we present microsequencing, immunologi-
cal, and functional data with an in vitro vesicle release as-
say that clearly demonstrate that the TGN-associated pro-
tein p200 (Narula et al., 1992) is a myosin II involved in
the release of VSVG transport vesicles from the TGN. A
19–amino acid fragment of p200 was 100% identical to a
tail region of human nonmuscle myosin, and gel-purified
p200 was recognized by platelet myosin II antibodies. Rat
liver cytosol immunodepleted of p200 had a 50–80% re-
duced ability to stimulate the release of VSVG transport
vesicles from the TGN of semiintact MDCK cells or puri-
fied Golgi fractions, and its activity in stimulating vesicle
release was efficiently reconstituted by human platelet and
chicken intestinal brush border myosin II, purified by non-
immune methods. Furthermore, immunodepletion of my-
osin II with specific antibodies resulted in comparable in-
hibition of VSVG transport vesicle release, which could be
overcome by addition of a myosin-enriched fraction.
The extent of the inhibitory effect of myosin depletion
from cytosol was dependent on the source of TGN trans-
port vesicles used in the in vitro assay. Whereas, in semiintact
cells, the inhibition of VSVG release by myosin-depleted
cytosol averaged z50%, in purified Golgi fractions it reached
up to 80%. The detection of VSVG release from both
semiintact cells and purified Golgi fractions required a high
salt wash, presumably to remove membrane bound myosin
II and other myosins or motors that could replace it. Over-
lapping roles of myosin and kinesin have been demon-
strated by gene knockout experiments in yeast, Aspergil-
lus, and Dictyostelium (Ostap and Pollard, 1996; Vale, 1993).
Under the conditions used in our assay studying vesicle re-
lease from purified Golgi, addition of cytosol caused a re-
lease of only 2–3% of the total sialyltransferase, whereas
the release of VSVG protein was in the range of 20–30%
of Golgi protein.
Specific myosin function data provided important addi-
tional support for a role of myosin II in vesicle release
from the TGN: (a) the S1 fragment of muscle myosin II
competed effectively with the membrane recruitment of
nonmuscle myosin II and inhibited the release of VSVG
transport vesicles; (b) the 20-kD COOH-terminal frag-
Figure 10. BDM inhibits the
release of VSVG-containing
vesicles from the TGN in
vitro and delays VSVG
transport from the TGN to
the surface in vivo, but it has
no effect on post-TGN trans-
port of HA in vitro and se-
cretion of apical proteins in
vivo. (A) BDM effect on ves-
icle release from the TGN in
vitro. Supernatant fractions
of a vesicle release assay with
VSVG (left) or HA (right) in
the absence (lane 1) or pres-
ence (lanes 2–5) of cytosol.
(Lanes  4 and 5) Both cytosol
and semiintact cells were pre-
incubated separately with 10
mM BDM for 5 min before
the assay was started. VSVG
transport vesicles were sedi-
mented and immunoprecipi-
tated with either p200 anti-
bodies in the absence of
Triton or VSVG antibodies
after Triton solubilization of
the membranes, whereas HA transport vesicles were precipitated with antibodies against HA in the presence of Triton only. (Lower
panel) Quantitation of the data from two independent experiments for HA and VSVG. (B) Effect of BDM on TGN to surface trans-
port of VSVG and secretion of apical and basolateral proteins in vivo. Filter-grown MDCK cells were pulse labeled after VSV infection
and radiolabeled VSVG accumulated in the TGN (time 0). Surface transport of VSVG (second column) and release of VSVG-contain-
ing viruses into the basolateral medium (third column) was measured after a 15-min incubation at 378C in the absence (solid bars) or
presence (striped bars) of 20 mM BDM. (Fourth through ninth columns) Uninfected cells were processed in the same way as the VSV-
infected ones, and total radioactivity in the basolateral (fourth through sixth columns) and apical (seventh through ninth columns) me-
dium was measured after a 15-min (fifth and eight columns) or 30-min (sixth and ninth columns) transport in the absence (solid bars) or
presence (striped bars) of 20 mM BDM. Each bar with standard error results from nine data points established in three individual ex-
periments. * Significant difference between 6 BDM by t test (P , 0.05).Müsch et al. Myosin in Vesicle Budding from the TGN 303
ment of caldesmon, an inhibitor of actin/myosin binding,
also inhibited VSVG protein release; (c) butanedione mon-
oxime, an inhibitor of myosin ATPase activity in muscle
and nonmuscle cells, reduced in vitro release of VSVG
vesicles; and (d) importantly, BDM also inhibited basolat-
eral delivery of VSVG and basolateral secretion in vivo,
but not apical delivery, suggesting that myosin is involved
specifically in basolateral transport (Fig. 10). The smaller
and transient BDM effects observed in vivo may result
from compensation by the cells using alternative routes
and/or from inactivation of the drug.
Several lines of evidence demonstrate that the release of
VSVG observed in our in vitro assay is indeed in TGN-
derived basolateral transport vesicles and cannot be ac-
counted for by nonspecific Golgi fragmentation. First,
p200 or myosin II depletion did not affect the release of
HA from the TGN, suggesting that a different apical sort-
ing machinery is involved in the release of this protein and
ruling out a nonspecific effect of myosin depletion on vesi-
cle release from the TGN. Second, the release of an intrin-
sic TGN marker, sialyltransferase, under our assay condi-
tions was insignificant when compared with that of VSVG
protein (Fig. 4). Third, immuno-EM analysis of TGN frac-
tions incubated under conditions that stimulate vesicle re-
lease demonstrated the colocalization of VSVG protein
and p200 in vesicles of 70–80 nm (Fig. 3). Fourth, rab 8, a
marker for basolateral vesicles (Huber et al., 1993), was
detected on the p200 immunoisolated vesicles, but not
b-COP, a coat protein found in the Golgi and to a lesser
extent in the TGN.
Table I. Distribution and Specific Activities of Marker Proteins for Different Organelles in a Golgi Preparation
Fraction
Sialyltransferase
(TGN)
Mannosidase II
(Golgi)
Glucosidase II
(ER)
Cathepsin D
(lysosomes)
Succinate dehydrogenase
(mitochondria)
Streptavidin
(plasma membrane)
gp114
(plasma membrane)
Nuclear pellet – 1.07 0.15 0.81 0.46 – –
Postnuclear supernatant 1 1 1 1 1 1 1
Mitochondria – 0.15 0.18 1.17 0.36 – –
Postmitochondrial supernatant – 1.4 0.69 0.46 0.13 1.17 0.54
Golgi 4.7 3.8 0.19 0.12 0.01 0.05 0.04
Specific enrichment of marker proteins for subcellular organelles in different steps of a Golgi preparation. Golgi-enriched MDCK membranes were prepared, and the enzymatic
activities of sialyltransferase, mannosidase II, glucosidase II, and succinate dehydrogenase were measured as described in Materials and Methods for equal amounts of total pro-
tein. Equal amounts of protein were also analyzed in immunoblots for the plasma membrane marker gp114 and the mature form of the lysosomal marker cathepsin D. Dot blots
were probed for streptavidin that bound to cell surface proteins that had been biotinylated before the preparation. Blots were probed with 125I–protein A or 125I-streptavidin, and the
bands in the corresponding autoradiographs were quantified as described in Materials and Methods. All data were normalized for the postnuclear supernatant.
Figure 11. Myosin binding to
isolated Golgi membranes is
actin dependent, BFA sensi-
tive, and regulated by tri-
meric G proteins. (A) A Golgi-
enriched membrane fraction
was washed with 0.6 M KI
and then incubated with rat
liver cytosol (lanes 2–7) in
the presence of 1 mM GTPgS
(lanes 1 and 2), 1 mM GTP
(lane  3), 5 mM Mg-ATP
(lane  4), 1 mM GTPgS and 5
mM Mg-ATP (lane 5), no en-
ergy (lane 6), and AlFx (50
mM AlCl3, 30 mM NaF)
(lane  7) for 30 min at 378C.
Unbound cytosolic proteins
were removed from the
membrane fraction by two
washes with buffer. Mem-
brane-bound myosin was de-
tected by immunoblot analy-
sis with a myosin antibody.
(B) A Golgi recruitment as-
say was performed as in A. All samples, except the sample in lane 1, were incubated with cytosol. 1 mM GTP was present in all samples
except for the sample in lane 5, which was incubated with AlFx. 10 mM BFA was included in the recruitment assay where indicated. The
membranes were probed for the recruitment of myosin and actin. (C) Phalloidin-polymerized actin filaments were removed from the cy-
tosol by precipitation in the presence of ATP. Actin-depleted cytosol (lane 8); control cytosol (lane 7) immunoblotted with actin and
myosin antibodies. When the depletion of actin is performed in the absence of ATP, the actin pellet also contains myosin (lane 10). My-
osin was released from the complex with actin as described for Fig. 1 A (lane 9). Lanes 1–6 represent immunoblots of Golgi-enriched
membrane fractions that were incubated with control cytosol (lane 2), actin-depleted cytosol (lane 3), and actin-depleted cytosol that
was supplemented with myosin only. 1 U/ml apyrase was included to hydrolyze the ATP present in the myosin sample (lane 4), actin-
depleted cytosol that was supplemented with actin and myosin (lane 6), or the pelleted actin/myosin complex alone (lane 5).The Journal of Cell Biology, Volume 138, 1997 304
Discrepant Results with Ikonen et al. (1996)
Our results contradict a recent report by Ikonen et al.
(1996), which confirmed the TGN localization of p200 to
vesicles and tubular structures by immuno-EM but re-
ported (a) no effect of p200 depletion on VSVG transport
from TGN to plasma membrane in streptolysin O–perme-
abilized cells; (b) no colocalization of p200 with VSVG
protein; and (c) no p200 in VSVG vesicles floated in su-
crose density gradients. We will discuss these discrepan-
cies in order.
(a) We suggest that the failure to observe an effect of
p200 depletion on VSVG transport can be explained by
the requirement (discussed above) for a high salt wash to
observe an effect of myosin depletion in semiintact cells.
In their assay for transport, originally developed by Gra-
votta et al. (1990), transport of VSVG or influenza HA to
their respective cell surfaces is studied after addition of
streptolysin O to the opposite surface to allow the exit of
cytosol. As the Simons group has previously reported,
transport of HA or VSVG to the cell surface can be ob-
served only if cytosol removal is ,70%; under these condi-
tions, a weak, usually less than twofold stimulation is ob-
served (Pimplikar et al., 1994). Given that cytosolic myosin
is one of the most abundant cellular proteins (z1–5% of
total cellular protein), and that our data indicate that a
high salt wash is required to observe cytosol-dependent re-
lease of VSVG in semiintact cells (Müsch et al., 1996, and
this paper), it is therefore not surprising that p200 deple-
tion from cytosol had no effect of VSVG transport in
streptolysin O–permeabilized MDCK cells.
(b) In their studies, Ikonen et al. (1996) use an anti-tail
antibody and immunogold to localize VSVG in MDCK
cells ripped by the addition of filter paper to the apical sur-
face; under these conditions, VSVG localizes to structures
that look different from the TGN-like tubules and vesicu-
lar structures rich in p200. On the other hand, our results
demonstrate colocalization of VSVG and p200 in tubules
and vesicles (Fig. 3) if antibodies against VSVG ectodomain
are used on samples that have been previously fixed and
disrupted with detergent. These results suggest that the
absence of VSVG tail antibody labeling in p200-rich struc-
tures may be due to steric interference by coat proteins and
p200/myosin recruited to the TGN. Furthermore, Griffiths
et al. (1985) failed to detect VSVG protein accumulated in
the TGN by a 208C transport block with the anti-tail anti-
bodies in regions of the TGN that contained coated buds.
(c) Ikonen et al. (1996) failed to find p200 immunoreac-
tivity in VSVG-rich vesicles purified by flotation in a su-
crose gradient, from assays performed in the presence of
guanyl-imidodiphosphate to promote membrane associa-
tion of p200. Our results indicate, on the other hand, that
vesicles isolated with p200 antibodies from the superna-
tant of our in vitro assay contain a large fraction of VSVG,
z80%, in the presence of GTPgS (Fig. 2 B), and that pre-
cipitation of VSVG by p200 antibody is less efficient in the
absence of GTPgS (z30%), indicating that p200 and coat
proteins may be quickly removed by uncoating in the pres-
ence of GTP. It is well demonstrated that GTPgS does not
inhibit the release of VSVG vesicles but prevents uncoat-
ing (Simon et al., 1996, and this paper); however, the ef-
fects of guanyl-imidodiphosphate on both p200 recruit-
ment and on the efficiency of VSVG vesicle release were
characterized by neither Ikonen et al. (1996) nor others.
Binding of Myosin to Golgi Membranes Involves G 
Proteins and Actin
Myosin II found in association with the Golgi complex
showed binding properties characteristic of coat proteins
involved in vesicle assembly. The binding of myosin to
Golgi membranes was dependent on GTP or its nonhydro-
lyzable homologue GTPgS and was stimulated by AlFx,
supporting a contribution of trimeric G proteins. Brefeldin
A, which prevents the recruitment of the small GTP bind-
ing protein ARF to Golgi membranes (Helms and Roth-
man, 1992; Robinson and Kreis, 1992) and causes tubula-
tion of the TGN in MDCK cells (Wagner et al., 1994), is
also effective in inhibiting myosin recruitment to the
Golgi. AlFx also significantly stimulated the recruitment of
myosin to the perinuclear regions in intact MDCK cells
(Fig. 6); 10 mg/ml BFA effectively dispersed this perinu-
clear p200/myosin staining (Cohen, D., A. Müsch, and E.
Rodriguez-Boulan, unpublished results). The same BFA
concentration also inhibits the release of VSVG-contain-
ing vesicles from the TGN in the semiintact cell assay
(Müsch, A., and E. Rodriguez-Boulan, unpublished re-
sults). Identical features for recruitment to Golgi mem-
branes have been reported for coatomers and AP1/clath-
rin, the binding of which to the Golgi requires ARF1 (Orci
et al., 1993a,b; Stamnes and Rothman, 1993; Traub et al.,
1993). Thus, our results suggest that myosin either is part
of a coat complex itself or is recruited to the site of vesicle
budding subsequent to coat assembly to participate in ves-
icle fission, as described for the fission of clathrin-coated
endocytic vesicles by dynamin, a GTP-dependent motor
(Damke et al., 1995; Hinshaw and Schmid, 1995; Takel et
al., 1995). Indeed, in Saccharomyces cerevisiae, the forma-
tion of endocytic vesicles has been recently shown to be
dependent on the expression of myosin I; two myosin I iso-
forms have been characterized that can complement each
other in promoting endocytosis (Geli and Riezman, 1996).
In Dictyostelium, several myosin I isoforms seem to have
overlapping functions in pinocytosis and phagocytosis, ex-
plaining the absence of a phenotype after knockout of just
one of the several myosin I genes (Jung et al., 1996). The
involvement of actin filaments in endocytic vesicle forma-
tion had been suggested indirectly by pharmacologic ex-
periments. In yeast, disruption of actin filaments by cy-
tochalasin D resulted in the accumulation of coated pits at
the plasma membrane (Kuebler and Riezman, 1993). A
similar phenomenon was reported for the apical mem-
brane of polarized epithelial cells (Gottlieb et al., 1993).
Recently, certain dynamin isoforms have been detected at
the Golgi complex, suggesting that dynamin and myosin
could have roles in vesicle transport both in exocytosis and
endocytosis (Henley and McNiven, 1996).
The inhibition of VSVG transport vesicle formation by
S1, caldesmon, and BDM, which prevent the interaction of
myosin with actin (Figs. 9 and 10), suggests that the actin-
dependent ATPase activity of myosin is involved in this
process. The involvement of actin in the release of VSVG
transport vesicles is also supported by experiments in
which depletion of phalloidin-polymerized actin from cy-Müsch et al. Myosin in Vesicle Budding from the TGN 305
tosol prevented myosin recruitment to Golgi membranes;
only the addition of resuspended actin restored myosin re-
cruitment (Fig. 11). Furthermore, addition of ATP together
with GTPgS inhibited membrane recruitment of myosin,
consistent with this process of being mediated by actin and
therefore readily abolished by ATP hydrolysis. Interest-
ingly, the binding of actin to Golgi membranes, like myo-
sin binding, was dependent on GTP, regulated by trimeric
G proteins, and BFA sensitive, in agreement with a close
interaction of both molecules during binding. In this re-
spect, it is noteworthy that a dynamic cytoskeleton has been
recently detected at the Golgi, which contains b-spectrin
(Beck et al., 1994). Independently, the presence of ankyrin
at the Golgi has been reported (Devarajan et al., 1996).
Although the structure and links of this new cytoskeletal
network are still obscure, recent data suggest that it medi-
ates the interaction of the Golgi with microtubules via the
binding of Golgi spectrin to the actin-related protein, cen-
tractin (Holleran et al., 1996). Centractin is part of the dy-
nactin complex that contains the microtubular motor dy-
nein that has been detected earlier at the Golgi (Fath et
al., 1994). Similary, the spectrin cytoskeleton might con-
nect the Golgi with actin filaments. The assembly of the
spectrin cytoskeleton at the Golgi is dynamic and sensitive
to BFA (Beck et al., 1994). It is tempting to speculate that
the binding of actin to Golgi membranes described in this
report might be mediated by the spectrin/ankyrin cytoskel-
eton, as described for the plasma membrane (Bennett,
1989). Myosin, in this scenario, might move actin filaments
to either pull a bud or to move away vesicles from the do-
nor membrane. Alternatively, myosin might promote actin
rearrangements and local dissolution of the Golgi cytoskel-
eton, thus allowing coat protein recruitment and vesicle
budding. Actin rearrangements of this sort have been sug-
gested to be essential for both exo- and endocytic events at
the plasma membrane (Bretscher, 1991; Jung and Ham-
mer, 1990; Maniak et al., 1995; Muallem et al., 1995; Sand-
vig and van Deurs, 1990). In this scenario, myosin might
regulate the dynamics of a spectrin-based Golgi skeleton
that directly or indirectly participates in the formation of
buds and vesicles, as suggested by Beck and Nelson
(1996). Further studies are needed to determine whether a
rearrangement of the actin cytoskeleton might also be nec-
essary for other vesicle budding events in the TGN. The
participation of myosin I in a late step in apical transport
has been demonstrated (Fath and Burgess, 1993). Indeed,
although our current data do not support the involvement
of myosin in vesicular release of HA, this could be the re-
sult of the full preservation of the actin cytoskeleton in
MDCK cells infected with influenza virus (Salas el al.,
1986). The intense disruption of the actin cytoskeleton
caused by VSV infection might allow the in vitro vesicle
budding assay to be more sensitive to myosin depletion.
The important advances made in the identification of
novel myosins in recent years (Hasson and Mooseker,
1995; Mooseker and Cheney, 1995) predict a plethora of
trafficking functions for these molecules that are waiting
to be discovered.
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